AWMGS launches a new genomic service for patients with urothelial carcinoma.

AWMGS are pleased to announce the launch of a new genomic service for patients with metastatic or unresectable FGFR-altered urothelial carcinoma.

Request forms for this service can be found here

Clinical Guidance document for this service can be found here

Any questions regarding any of these services can be sent to This email address is being protected from spambots. You need JavaScript enabled to view it.